June 8, 2005

Bayer aims for bigger share of Korea's veterinary market 
 

Bayer Healthcare aims to garner a greater market share in South Korea-and the Asia-Pacific region-by focusing more on its veterinary division.

South Korea is one of Bayer HealthCare's core strategic growth areas in Asia-Pacific. Last year alone, Korea accounted for 15 per cent of Bayer's growth and is ranked as its second-largest market in the Asia-Pacific region, after Australia.

The strong performance has resulted in the German pharmaceuticals giant, which has been synonymous with the classic pain reliever Aspirin, giving greater attention to Asia.

The company's products currently concentrate on vaccines and feed additives to prevent diseases in food-chain livestock to ensure a safe food supply. Farm sanitization products are also a major component.

Bayer has targeted a 6 per cent growth this year in Korea.